We are live on ! Find out more
AssetMark Inc

AssetMark Inc Portfolio holdings

AUM $58.2B
1-Year Est. Return 22.78%
This Fund
S&P 500
This Quarter Est. Return
+8.68%
1 Year Est. Return
+22.78%
3 Year Est. Return
+68.16%
5 Year Est. Return
+68.87%
10 Year Est. Return
+184.44%
AUM
$30.8B
AUM Growth
+$3.09B
Cap. Flow
+$990M
Cap. Flow %
3.22%
Top 10 Hldgs %
29.6%
Holding
2,170
New
323
Increased
801
Reduced
650
Closed
240

Sector Composition

Rank Sector Weight
1 Miscellaneous 69.13%
2 Technology 8.72%
3 Healthcare 4.15%
4 Financials 3.8%
5 Communication Services 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSY icon
701
Hershey
HSY
$34.5B
$1.13M ﹤0.01%
5,821
+922
+19% +$178K
CROX icon
702
Crocs
CROX
$5.48B
$1.13M ﹤0.01%
7,860
-968
-11% -$110K
REG icon
703
Regency Centers
REG
$13.5B
$1.13M ﹤0.01%
18,640
+1,933
+12% +$120K
IDYA icon
704
IDEAYA Biosciences
IDYA
$3.64B
$1.13M ﹤0.01%
+25,691
New +$1.1M
ITW icon
705
Illinois Tool Works
ITW
$76.7B
$1.11M ﹤0.01%
4,123
+1,288
+45% +$334K
HYXF icon
706
iShares ESG Advanced High Yield Corporate Bond ETF
HYXF
$193M
$1.11M ﹤0.01%
24,187
+227
+0.9% +$10.3K
FAAR icon
707
First Trust Alternative Absolute Return Strategy ETF
FAAR
$219M
$1.1M ﹤0.01%
38,311
+10,756
+39% +$303K
HODL icon
708
VanEck Bitcoin Trust
HODL
$1.26B
$1.1M ﹤0.01%
+54,912
New +$850K
SUB icon
709
iShares Short-Term National Muni Bond ETF
SUB
$11.6B
$1.1M ﹤0.01%
10,493
+1,522
+17% +$160K
ALLE icon
710
Allegion
ALLE
$13.1B
$1.1M ﹤0.01%
8,142
+71
+0.9% +$9.09K
DLB icon
711
Dolby
DLB
$5.63B
$1.1M ﹤0.01%
13,092
+2,547
+24% +$211K
SRPT icon
712
Sarepta Therapeutics
SRPT
$2.13B
$1.1M ﹤0.01%
8,467
+1,800
+27% +$220K
CPRX
713
DELISTED
Catalyst Pharmaceutical
CPRX
$1.09M ﹤0.01%
68,675
+3,997
+6% +$60.2K
CHTR icon
714
Charter Communications
CHTR
$16.5B
$1.09M ﹤0.01%
3,741
+3,731
+37,310% +$1.2M
BIIB icon
715
Biogen
BIIB
$32B
$1.08M ﹤0.01%
4,997
-38
-0.8% -$8.9K
KVUE icon
716
Kenvue
KVUE
$34.3B
$1.08M ﹤0.01%
50,146
+10,151
+25% +$206K
ESPO icon
717
VanEck Video Gaming and eSports ETF
ESPO
$253M
$1.07M ﹤0.01%
17,096
+9,827
+135% +$588K
SUPN icon
718
Supernus Pharmaceuticals
SUPN
$2.38B
$1.06M ﹤0.01%
31,102
+1,403
+5% +$41.8K
AES icon
719
AES
AES
$10.6B
$1.06M ﹤0.01%
59,062
+7,489
+15% +$125K
EXC icon
720
Exelon
EXC
$43.9B
$1.05M ﹤0.01%
28,026
-149
-0.5% -$5.32K
TAK icon
721
Takeda Pharmaceutical
TAK
$59.9B
$1.05M ﹤0.01%
75,592
+3,864
+5% +$56.2K
SLQD icon
722
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.43B
$1.05M ﹤0.01%
21,276
-5,928
-22% -$291K
EXPE icon
723
Expedia Group
EXPE
$34.7B
$1.05M ﹤0.01%
7,602
+7,593
+84,367% +$1.08M
GGG icon
724
Graco
GGG
$12.5B
$1.05M ﹤0.01%
11,200
+2,204
+24% +$195K
CALF icon
725
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.84B
$1.04M ﹤0.01%
21,200
+20,980
+9,536% +$998K

Similar funds

AssetMark Inc's Q1 2024 Portfolio in Review

As of Q1 2024, AssetMark Inc held 2,170 positions worth $30.8B, up 11% from $27.7B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

AssetMark Inc deployed $990M of net new capital in Q1 2024, opening 323 new positions and adding to 801 existing holdings. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,297,222 shares worth $101M.

By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 70% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was ProShares Ultra S&P500, an estimated $326M trimmed.

  • AssetMark Inc's largest Q1 2024 buy was Vanguard Long-Term Corporate Bond ETF: 1,297,222 shares worth $101M.
  • AssetMark Inc added most to iShares 1-3 Year Treasury Bond ETF in Q1 2024, an estimated $350M increase.
  • AssetMark Inc's biggest Q1 2024 reduction was ProShares Ultra S&P500, cutting an estimated $326M.
  • AssetMark Inc fully exited ProShares UltraPro S&P 500 in Q1 2024, selling an estimated $16.8M.
  • AssetMark Inc's ten largest holdings make up 30% of its $30.8B portfolio in Q1 2024.
  • AssetMark Inc opened 323 new positions and closed 240 in Q1 2024.
  • AssetMark Inc's portfolio value rose 11% quarter-over-quarter to $30.8B.

Based on AssetMark Inc's 13F filing for Q1 2024, filed 7 May 2024.